Glucocorticoid suppression of oestrus, follicles, LH and ovulation in the mare.

The research article explores how dexamethasone, a synthetic glucocorticoid, can influence ovulation and related processes in mares.

Overview of the Research

• The researchers designed an experiment to examine the effect of glucocorticoids—specifically dexamethasone—on the ovulatory cycle of mares. They aimed to understand the role of the adrenal glands in this process.
• Dexamethasone was administered at a dosage of 30mg per day, starting from Day 10 after ovulation.

Key Findings

• Behavioral oestrus: Of the 8 mares treated with dexamethasone, only 1 showed signs of behavioural oestrus, compared to 7 out of 8 mares in the control group that didn’t receive dexamethasone. Behavioral oestrus refers to the period when female mammals are receptive to mating.
• LH concentration and follicle size: The average maximum luteinizing hormone (LH) concentration and follicle size in the treated mares were observed to be significantly lower in comparison with the control mares. LH is a hormone that contributes to the ovulatory cycle, specifically in the release of eggs from the ovaries, while follicle size could influence egg quality and development.
• Ovulation: Ovulation was recorded in 1, and possibly 2, of the treated mares, whereas all 8 mares in the control group ovulated. This suggests that dexamethasone treatment might inhibit or delay ovulation.

Implications and Conclusions

The study implied that dexamethasone, a synthetic glucocorticoid, can potentially interfere with ovulation and the events associated with it in mares. However, the exact mechanism through which it exerts this effect remains unclear. This research contributes to understanding the role of the adrenal glands in the ovulatory cycle and may have implications on fertility treatments and breeding programs in horses. Further studies are required to unravel the complex dynamics of hormonal regulations involved in ovulation.